RxDoctor Payments Data

Jaremy James

Internal Medicine · Mansfield, TXNPI 1063730505

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 83 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Novo Nordisk at 26.8% of the total. Reporting peaked in 2019 at $966 and has fallen 98.3% since, to $16 in 2025.

$1,115in general payments, 2019–2025

Across 83 payments — averaging $13.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$299
  • Pfizer$144
  • Lilly USA, LLC$116
  • Kowa Pharmaceuticals America, Inc.$78
  • Amgen$64
  • Takeda Pharmaceuticals U.S.A., Inc.$60
  • plus $354 from 13 others

What the payments were for

  • Food & beverage$1,115100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,115 in reported general payments places this provider in the 70th percentile of 7,675 internal medicine providers in Texas.

See all internal medicine providers in Texas →

Other internal medicine in Mansfield

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →